MOH — authorised 6 March 2018
- Marketing authorisation holder: TAIMED BIOLOGICS USA
- Status: likely_approved
MOH authorised Trogarzo on 6 March 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 6 March 2018.
TAIMED BIOLOGICS USA holds the Israeli marketing authorisation.